Pycnogenol® French maritime pine bark extract in randomized, double-blind, placebo-controlled human clinical studies
- PMID: 38757130
- PMCID: PMC11096518
- DOI: 10.3389/fnut.2024.1389374
Pycnogenol® French maritime pine bark extract in randomized, double-blind, placebo-controlled human clinical studies
Abstract
Pycnogenol® French maritime pine bark extract is a well-known and thoroughly studied patented extract from the bark of Pinus pinaster Ait. ssp. Atlantica. In 39 randomized double-blind, placebo-controlled (RDP) human clinical trials including 2,009 subjects, Pycnogenol® French maritime pine bark extract supplementation for two weeks to six months has been shown to beneficially affect cardiovascular health, chronic venous insufficiency, cognition, joint health, skin health, eye health, women's health, respiratory health and allergies, oral health and sports performance. The mechanisms of action that can explain the respective effects on different conditions in the human body are discussed as well. As investigated in several in vitro, in vivo and in clinical studies, Pycnogenol® French maritime pine bark extract showed antioxidative effects, anti-inflammatory abilities, beneficial effects on endothelial function and reinforcing effects on the extracellular matrix. The present review aims to give a comprehensive overview of currently available "gold standard" RDP trials of Pycnogenol®'s benefits across various health domains compared to placebo. In addition, some of the processes on which the presented effects of Pycnogenol® French maritime pine bark extract are based will be elucidated and discussed. This broad overview of RDP studies on Pycnogenol® in different health domains can be used as a basis for further research on applications and mechanisms of this unique French maritime pine bark extract.
Keywords: Pycnogenol®; anti-inflammatory; antioxidant; cardiovascular; double-blind; endothelial health; pine bark extract; placebo-controlled.
Copyright © 2024 Weichmann and Rohdewald.
Conflict of interest statement
FW was an employee of Horphag Research. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Impact of a Dietary Supplementation with French Maritime Pine Bark Extract Pycnogenol® on Salivary and Serum Inflammatory Biomarkers During Non-Surgical Periodontal Therapy-A Randomized Placebo-Controlled Double-Blind Trial.Nutrients. 2025 Apr 30;17(9):1546. doi: 10.3390/nu17091546. Nutrients. 2025. PMID: 40362854 Free PMC article. Clinical Trial.
-
Pleiotropic Effects of French Maritime Pine Bark Extract to Promote Healthy Aging.Rejuvenation Res. 2019 Jun;22(3):210-217. doi: 10.1089/rej.2018.2095. Epub 2018 Dec 12. Rejuvenation Res. 2019. PMID: 30215292
-
Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study.Eur Heart J. 2012 Jul;33(13):1589-97. doi: 10.1093/eurheartj/ehr482. Epub 2012 Jan 11. Eur Heart J. 2012. PMID: 22240497 Clinical Trial.
-
Review of the pharmacokinetics of French maritime pine bark extract (Pycnogenol®) in humans.Front Nutr. 2024 May 2;11:1389422. doi: 10.3389/fnut.2024.1389422. eCollection 2024. Front Nutr. 2024. PMID: 38757126 Free PMC article. Review.
-
Review on Sustained Relief of Osteoarthritis Symptoms with a Proprietary Extract from Pine Bark, Pycnogenol.J Med Food. 2018 Jan;21(1):1-4. doi: 10.1089/jmf.2017.0015. Epub 2017 Aug 24. J Med Food. 2018. PMID: 28836883 Free PMC article. Review.
Cited by
-
Antioxidant potential of tree bark extracts: Insight from the multi-level output of the Antioxidant Power 1 assay.PLoS One. 2025 Jul 28;20(7):e0328790. doi: 10.1371/journal.pone.0328790. eCollection 2025. PLoS One. 2025. PMID: 40720417 Free PMC article.
-
Lifestyle interventions in later reproductive age women to offset cardiometabolic and bone disease: a scoping review.Nutr Metab (Lond). 2025 Feb 25;22(1):15. doi: 10.1186/s12986-025-00908-1. Nutr Metab (Lond). 2025. PMID: 40001044 Free PMC article. Review.
-
Does supplementation with pine bark extract improve cardiometabolic risk factors? A systematic review and meta-analysis.BMC Complement Med Ther. 2025 Feb 22;25(1):71. doi: 10.1186/s12906-025-04819-9. BMC Complement Med Ther. 2025. PMID: 39987124 Free PMC article.
-
Impact of a Dietary Supplementation with French Maritime Pine Bark Extract Pycnogenol® on Salivary and Serum Inflammatory Biomarkers During Non-Surgical Periodontal Therapy-A Randomized Placebo-Controlled Double-Blind Trial.Nutrients. 2025 Apr 30;17(9):1546. doi: 10.3390/nu17091546. Nutrients. 2025. PMID: 40362854 Free PMC article. Clinical Trial.
-
Leveraging crude extracts from European tree bark to combat oxidative stress, enhance wound healing, and inhibit pathogenic bacterial growth.Sci Rep. 2025 Jul 1;15(1):21340. doi: 10.1038/s41598-025-06105-7. Sci Rep. 2025. PMID: 40596045 Free PMC article.
References
-
- Karaçelik AA, Şeker ME, Karaköse M. Determination of antioxidant activity of different extracts from bark of Pinus spp. grown in Giresun (Turkey) province – phenolic analysis by RP-HPLC-DAD. KSU J Agric Nat. (2022) 25:10–8. 10.18016/ksutarimdoga.vi.875313 - DOI
-
- Oliff H. Scientific and clinical monograph for Pycnogenol. Austin, TX: American Botanical Council; (2019). p. 1–46.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials